Register for Zoom In on Dementia & Alzheimer’s: Clinical Research
Register to join our free virtual program and engage in a live conversation with experts in the field.
TOPIC
Navigating Clinical Trials for Alzheimer’s Disease
DATE
Thursday, February 6, 2025
TIME
1 pm ET (please adjust for your time zone)
SPEAKER(S)
Jeffrey L. Cummings, MD, ScD
Once registered, you will receive an email with the link to join the Zoom meeting or a phone number to call in on the intended day of event.
Registration is closed for the February 6th program “Navigating Clinical Trials for Alzheimer’s Disease”
You can still watch live on Thursday, February 6th at 1 pm ET / 10am PT at this link: https://www.youtube.com/live/_JFPy6x-ro4
Watch Past Episodes
Can Lifestyle Changes Prevent Alzheimer’s? What the Research Reveals
Join us as lead scientist Dr. Miia Kivipelto discusses the science behind lifestyle interventions for reducing Alzheimer’s risk.
BIO-HERMES-002: Innovative Study to Advance Precise Alzheimer’s Diagnosis
Learn about the Bio-Hermes-002 study exploring blood and digital biomarkers for predicting Alzheimer’s pathology. Discover accessible detection methods and treatment eligibility.
Blood Tests for Alzheimer’s Disease: An Overview
Join us to learn the basics of what blood biomarkers are, how they work, and why they’re considered a game-changer in Alzheimer’s research and clinical care.
How Is Dementia Diagnosed?
Alzheimer’s expert Dr. David Holtzman shares insights on the latest diagnostic methods, when and how to seek a diagnosis, and how to navigate the process.
The START Study: Testing an Oral Capsule That May Protect Brain Synapses
Listen to lead research scientist Dr. Christopher van Dyck to learn more.
Frontotemporal Dementia: Diagnosis, Trials & Treatment
Scientists are rapidly gaining knowledge about the detection, diagnosis and treatment of FTD. Find the latest information and clinical trials for FTD.
The HOPE Study: Testing a Non-invasive, Light and Sound Stimulation Treatment for Alzheimer’s
Cognito Therapeutics CEO Brent Vaughan spoke about the pivotal HOPE Study, which uses an investigational medical device consisting of headphones and eyewear to deliver sensory stimulation treatment in the comfort of people’s homes.
The New Alzheimer’s Drug: What is Kisunla?
Dr. Paul Aisen answers your top questions on Kisunla, a new Alzheimer’s drug.
The Role of Genetics in Early Diagnosis and Treatment of Dementia
Explore the importance of understanding your genetic risk for Alzheimer’s and related dementias.